Neuroscientific Biopharmaceuticals Ltd News

Neuroscientific Biopharmaceuticals Ltd: Appendix 4G & Corporate Governance Statement

Aug 29 17:21

Neuroscientific Biopharmaceuticals Ltd: 2024 Annual Report & Appendix 4E

Aug 29 17:21

Neuroscientific Biopharmaceuticals Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jul 19 07:43

Neuroscientific Biopharmaceuticals Ltd: Notice of Release of Escrowed Securities

Jul 10 11:06

Neuroscientific Biopharmaceuticals Ltd: NSB Completes PRE-IND Meeting with US FDA on EmtinB

Jun 11 07:15

Neuroscientific Biopharmaceuticals Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 29 06:52

Neuroscientific Biopharmaceuticals Ltd: Notification of cessation of securities - NSB

Apr 8 10:04

Neuroscientific Biopharmaceuticals Ltd: Appointment of Executive Director & FDA Pre-Ind Meeting

Apr 2 06:26

Neuroscientific Biopharmaceuticals Ltd: NSB Receives A$2.2M Research & Development Tax Refund

Mar 20 06:39

Neuroscientific Biopharmaceuticals Ltd: Half Yearly Report and Accounts

Feb 27 14:43

Neuroscientific Biopharmaceuticals Ltd: Company Secretary Appointment/Resignation

Feb 6 06:52

Neuroscientific Biopharmaceuticals Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jan 31 06:55

Neuroscientific Biopharmaceuticals Ltd: Notification of cessation of securities - NSB

Jan 15 12:35

Neuroscientific Biopharmaceuticals Ltd: Expiry of Options

Dec 27, 2023 14:21

Neuroscientific Biopharmaceuticals Ltd: Final Director's Interest Notice - Rennie

Dec 7, 2023 10:11

Neuroscientific Biopharmaceuticals Ltd: Final Director's Interest Notice - Quantrill

Dec 5, 2023 16:50

Neuroscientific Biopharmaceuticals Ltd: Initial Director's Interest Notice - Keating

Dec 5, 2023 16:45

Neuroscientific Biopharmaceuticals Ltd: Changes to NSB Board

Dec 5, 2023 07:32

Neuroscientific Biopharmaceuticals Ltd: Resignation of CEO

Dec 1, 2023 09:11

Neuroscientific Biopharmaceuticals Ltd: Results of Meeting

Nov 30, 2023 13:59